Naphthalene

Naphthalene

SCHEMBL329434

[LiH].c1ccc2ccccc2c1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 7/20 0.89
ALOX12 P18054 1/20 0.89
ALDH1A1 P00352 7/20 0.50
HSD17B10 Q99714 6/20 0.50
TSHR P16473 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP1A2 P05177 5/20 0.44
CYP3A4 P08684 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
HPRT1 P00492 1/20 0.44
HPGD P15428 3/20 0.43
MAPT P10636 2/20 0.43
CYP1B1 Q16678 2/20 0.43
CYP1A1 P04798 1/20 0.43
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL466546 1.00 CYP2A6 (0.89) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL27520178 0.95 CYP2A6 (0.80) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL27341917 0.95 CYP2A6 (0.80) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL29358073 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL1332240 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL30685720 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL1330659 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL8613802 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL8953 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR
Naphthalene SCHEMBL1331142 0.94 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116581253-B Surface modified aluminum foil negative electrode, preparation method thereof and lithium ion battery CENTRAL SOUTH UNIVERSITY (CN) 2026-05-26 CN claimed
CN-119481065-B Preparation method of lithium slurry and product and application thereof 华中科技大学 2026-05-15 CN claimed
EP-4697412-A1 POSITIVE ELECTRODE ACTIVE MATERIAL COMPOSITION, POSITIVE ELECTRODE SHEET, BATTERY, AND ELECTRIC DEVICE Contemporary Amperex Technology Co., Limited (CN) 2026-02-18 EP claimed
US-12555776-B2 Anode materials for rechargeable lithium-ion batteries, and methods of making and using the same Tyfast Energy Corp. (US) 2026-02-17 US claimed
US-20250388995-A1 SYSTEMS AND METHODS FOR RECYCLING END-OF-LIFE BATTERY MATERIALS 24M TECH INC (US) 2025-12-25 US claimed
US-20250286050-A1 NEGATIVE ELECTRODE MATERIAL, NEGATIVE ELECTRODE PLATE, AND BATTERY ZHUHAI COSMX BATTERY CO., LTD. (CN) 2025-09-11 US claimed
CN-120079330-A System and process method capable of continuously preparing high first-effect silicon-carbon material 山东贝亿特科技有限公司 2025-06-03 CN claimed
CN-120058539-A Organic lithium supplementing agent, preparation method thereof and application thereof in positive electrode material 武汉中科先进材料科技有限公司 2025-05-30 CN claimed
CN-120054375-A System and process method capable of preparing high first-effect silicon-carbon material in large scale 山东贝亿特科技有限公司 2025-05-30 CN claimed
CN-120058538-A Organic lithium supplementing agent, preparation method thereof and application thereof in positive electrode material 武汉中科先进材料科技有限公司 2025-05-30 CN claimed
US-5561207-A USING COORDINATION CATALYST ELF ATOCHEM S.A. (FR) 1996-10-01 US claimed
US-5543021-A FROM PITCH COKE WITH MOSAIC TEXTURE LE CARBONE LORRAINE (FR) 1996-08-06 US claimed
CN-1113495-A Living random (meth) acrylic copolymers, copolymers prepared from these living copolymers and the corresponding... ATOCHEM ELF SA (FR) 1995-12-20 CN claimed
US-5395884-A Process for manufacturing multisequence star or network polycondensates by di- or multi-aldehyde coupling, and polycondensates obtained ELF ATOCHEM S.A. (FR) 1995-03-07 US claimed
CN-1076454-A With two or the coupling of many aldehyde prepare the method and the gained polycondensate of multichain section star or netted polycondensate ATOCHEM ELF SA (FR) 1993-09-22 CN claimed
US-4894409-A BLEND OR AMINO GROUP CONTAINING DIENE POLYMER AND SILICA FILLER NONCRACKING, WEAR RESISTANCE JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1990-01-16 US claimed
US-4504683-A Phospholes with functional substituents on the phosphorus and process for the preparation of phospholes INSTITUT NATIONAL DE RECHERCHE CHIMIQUE APPLIQUEE (IRCHA) (FR) 1985-03-12 US claimed
US-4485256-A FOR PREPARATION OF ADIPIC ACID E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-11-27 US claimed
US-RE29368-E GROUP 4B OR 6B, CYCLOPENTADIENYL LIGAND, ALKALI NAPTHALENE ALLIED CHEMICAL CORPORATION (US) 1977-08-23 US claimed
US-4029616-A Polymer composition of ethylenic compounds and pullulan SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-06-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12555776-B2 Anode materials for rechargeable lithium-ion batteries, and methods of making and using the same CACNA2D1, CACNA2D3, CACNA2D4 CYP2A6 3183/4885ALOX12 3285/4885ALDH1A1 2784/4885
US-20250388995-A1 SYSTEMS AND METHODS FOR RECYCLING END-OF-LIFE BATTERY MATERIALS WNT3A, WRN, L3MBTL3 CYP2A6 4797/4885ALOX12 4007/4885ALDH1A1 3197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.